USFDA
- Business
Usfda: USFDA pulls up Intas Pharma for manufacturing lapses at Ahmedabad plant
NEW DELHI: The US health regulator has pulled up Intas Pharmaceuticals for manufacturing lapses, including violation of current good manufacturing…
Read More » - Business
Aurobindo in-licenced chemotherapy induced neutropenia drug Ryzneuta gets USFDA nod, sends scrip soaring to 52-week high
HYDERABAD: Pharma major Aurobindo Pharma on Wednesday informed the bourses that the US Food & Drug Administration (USFDA) has approved…
Read More » - Business
High-level USFDA delegation visits Divi’s Labs manufacturing facilities in Hyderabad
HYDERABAD: In what is perhaps a first, a high-level delegation of the US drug regulator US Food & Drug Administration,…
Read More » - Business
Drug companies on toes amid glare on USFDA
MUMBAI: A US congressional panel has voiced concern on the ineffective action on quality lapses taken by its national drug…
Read More »